DFTX
Definium Therapeutics
DFTX
DFTX
248 hedge funds and large institutions have $1.47B invested in Definium Therapeutics in 2026 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 82 increasing their positions, 52 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
19% more funds holding
Funds holding: 208 → 248 (+40)
9.4% more ownership
Funds ownership: 68.89% → 78.29% (+9.4%)
Holders
248
Holding in Top 10
6
Calls
$32.5M
Puts
$8.45M
Top Buyers
| 1 | +$28M | |
| 2 | +$27.1M | |
| 3 | +$22.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$19.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$19.1M |
Top Sellers
| 1 | -$30.1M | |
| 2 | -$26.3M | |
| 3 | -$14.1M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$10.6M |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$10.6M |
